Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study von Julien, Karen, Leung, Hiu Tung, Fuertes, Carmen, Mori, Megumi, Wang, Miao‐Jen, Teo, Jocelyn, Weiss, Lisa, Hamilton, Sara, DiFebo, Holly, Noh, Yoon Jin, Galway, Aralee, Koh, Jane, Brutcher, Edith, Zhao, Huanyu, Shen, Yun, Tschaika, Marina, To, Yue‐Yun

Volltext

Spectrum and Clinical Significance of HLA Class I Alleles and Their Somatic Mutations in Immune Aplastic Anemia von Zaimoku, Yoshitaka, Adams, Sharon D., Patel, Bhavisha A, Lee, Audrey Ai Chin, Kajigaya, Sachiko, Feng, Xingmin, Rios, Olga, DiFebo, Holly, Alemu, Lemlem, Raffo, Diego Quinones, Groarke, Emma M., Flegel, Willy A., Young, Neal S.

Volltext

Final report of a phase I/II study of veliparib (Vel) in combination with 5-FU and oxaliplatin (FOLFOX) in patients (pts) with metastatic pancreatic cancer (mPDAC) von Pishvaian, Michael J., Wang, Hongkun, Parenti, Sarah, He, Aiwu Ruth, Hwang, Jimmy J., Ley, Lisa, Difebo, Holly, Smaglo, Brandon George, Kim, Sunnie S., Weinberg, Benjamin Adam, Weiner, Louis M., Marshall, John, Brody, Jonathan Robert

Volltext

Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression von Dauphinais, Deborah Rozenn, Rosenthal, Joshua Zev, Terman, Michael, DiFebo, Holly Marie, Tuggle, Catherine, Rosenthal, Norman Edward

Volltext